NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.100
+0.056 (5.36%)
At close: May 12, 2025, 4:00 PM
1.120
+0.020 (1.82%)
After-hours: May 12, 2025, 7:27 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $26.39 million as of May 12, 2025. Its market cap has increased by 20.82% in one year.
Market Cap
26.39M
Enterprise Value
23.08M
1-Year Change
20.82%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $26.39M, a decrease of -59.16%. That is a compound annual growth rate of -23.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 26.39M | -4.91% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |